Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic.
Gibbs
J B
JB
Department of Cancer Research, Merck Research Laboratories, West Point, Pennsylvania 19486.
Oliff
A
A
Kohl
N E
NE
D019883:Alkyl and Aryl Transferases; D000595:Amino Acid Sequence; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000188:drug therapy*; D015689:Oncogene Protein p21(ras) / Q000378:metabolism*; D017368:Protein Prenylation / Q000502:physiology*; D014166:Transferases / Q000037:antagonists & inhibitors*
D014166:Transferases; D019883:Alkyl and Aryl Transferases; C064911:p21(ras) farnesyl-protein transferase; D015689:Oncogene Protein p21(ras)